BioXyTran
About:
BioXyTran is a biopharmaceutical company that develops treatments for stroke and Ischemia.
Website: http://www.bioxytraninc.com
Top Investors: TRITON FUNDS LLC
Description:
BioXyTran operates as a biopharmaceutical company whose mission is to develop anti-necrosis drugs that treat a variety of medical conditions resulting from stroke and Ischemia. The company was founded in 2008 and is headquartered in Needham, Massachusetts.
Total Funding Amount:
$1.23M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Needham, Massachusetts, United States
Founded Date:
2008-01-01
Contact Email:
info(AT)bioxytraninc.com
Founders:
David Platt
Number of Employees:
1-10
Last Funding Date:
2023-06-12
IPO Status:
Public
Industries:
© 2025 bioDAO.ai